MedTrace Logo

Continuous Adductor Canal Block in Outpatient Total Knee Arthroplasty

NCT05100706 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-05-13

No results posted yet for this study

Summary

Total knee arthroplasty (TKA) is a frequent performed surgery. Many institutions are implementing outpatient programs for this surgery and adequate pain management is an important feature. Analgesic duration of single shot nerve blocks is limited to no more than 24h. Conversely, the use of continuous nerve block (CNB) through a perineural catheter and infusion of local anesthetic may increase duration of analgesia and provide better outcomes. The purpose of this study is to evaluate effectiveness and safety of using CNB in patients undergoing primary TKA, and its effects on patients' quality of recovery. We hypothesize that continuous adductor canal block would lead to a better quality of recovery in patients undergoing primary TKA.

Conditions

  • Knee Arthroplasty, Total
  • Anesthesia, Regional
  • Acute Pain

Interventions

DRUG

Continuous adductor canal block (CACB)

Ropivacaine 0.2% infusion through adductor canal catheter

DRUG

Sham continuous adductor canal block (ShACB).

NaCl 0.9% infusion through adductor canal catheter

Sponsors & Collaborators

  • MOUNT SINAI HOSPITAL

    collaborator OTHER

  • University of Toronto

    lead OTHER

Principal Investigators

  • Naveed Siddiqui, MD, MSc · University of Toronto

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-01
Primary Completion
2025-01-06
Completion
2025-06-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05100706 on ClinicalTrials.gov